Overview Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 Status: Completed Trial end date: 1969-12-31 Target enrollment: 0 Participant gender: All Summary The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone. Phase: Phase 2Accepts Healthy Volunteers? No Details Lead Sponsor: University of VermontCollaborator: National Institute on Drug Abuse (NIDA)Treatments: Buprenorphine Criteria Please contact site for information.